Figure (501b1d9e De62 4f0c 9233 Fa7af6df2057 01)
Minocycline Hydrochloride Tablet, Extended Release
Product Images NDC 70771-1154
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Minocycline Hydrochloride (NDC 70771-1154). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (501b1d9e De62 4f0c 9233 Fa7af6df2057 02)
This is a description of the prescription medication, Minocycline Hydrochloride, in extended-release tablet form. Each tablet contains 45mg of minocycline hydrachloride USP. The organic impurities procedure is still pending according to USP standards. The recommended dosage is available in the package insert. The medication should be stored at a controlled room temperature of 20° to 25°C (88° to 77°F) and protected from light, moisture, and excessive heat. This medication should be kept out of reach of children and dispensed in a tight, light-resistant container as defined in the USP. It is manufactured by Cadila Healthcare Ltd in Ahmedabad, India.*
Figure (501b1d9e De62 4f0c 9233 Fa7af6df2057 03)
This is a description of extended-release tablets containing minocycline hydrochloride USP equivalent to minocycline 80 mg. The tablets should be stored at 20° to 25°C (68° to 77°F), protected from light, moisture, and excessive heat as per USP Controlled Room Temperature. The dosage instructions can be found in the package insert, and the tablets should be stored in a tight, light-resistant container. The manufacturer is Cadila Healthcare Ltd. The text mentions that the organic impurities procedure for minocycline USP is still pending. It also warns to keep the medication out of children's reach.*
Figure (501b1d9e De62 4f0c 9233 Fa7af6df2057 04)
This is a medication used to treat bacterial infections. It comes in a pack of 100 extended-release tablets with each tablet containing minocycline hydrochloride USP equivalent to minocycline 90 mg. The usual dosage should be taken as per the package insert. It must be stored at 20° to 25°C (68° to 77°F) and protected from light, moisture, and excessive heat. The manufacturer is Cadila Healthcare Ltd located in Ahmedabad, India. There is a pending procedure for organic impurities in minocycline USP, and this medication should be kept away from children.*
Figure (501b1d9e De62 4f0c 9233 Fa7af6df2057 05)
This is a medication containing minocycline hydrochloride USP in extended-release tablet form. Each tablet has 105 mg of minocycline hydrochloride USP. The organic impurities procedure is still pending for minocycline hydrochloride USP. It should be stored in a tight, light-resistant container as per USP and kept out of reach of children. The manufacturer of this medication is Cadila Healthcare Ltd, located in India.*
Figure (501b1d9e De62 4f0c 9233 Fa7af6df2057 06)
This is a medication called minocycline hydrochloride that is in extended-release tablet form. Each tablet contains 135mg of minocycline. There is a pending procedure for testing organic impurities within the medication. The recommended dosage is available in the package insert. The tablets should be stored between 20°C and 25°C and protected from light, moisture and heat. It should be dispensed in a light-resistant container as defined by the USP. This medication should be kept out of the reach of children. It is manufactured by Cadila Healthcare Ltd and contains 100 tablets. The location of manufacturing is in Ahmedzbad, India and requires a prescription to purchase.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
